Company Valuation: Corbus Pharmaceuticals Holdings, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 77.1 13.84 26.72 143.7 150.8 56.57 - -
Change - -82.05% 93.01% 437.89% 4.94% -62.5% - -
Enterprise Value (EV) 77.1 13.84 26.72 143.7 150.8 56.57 56.57 56.57
Change - -82.05% 93.01% 437.89% 4.94% -62.5% 0% 0%
P/E -1.66x -0.33x -0.59x -3.21x -1.38x -0.44x -0.55x -0.52x
PBR - - - - - - - -
PEG - 0.04x -0.37x 0x -0x -0.08x 0x -0.08x
Capitalization / Revenue 87.4x - - - - - 28.1x 25.3x
EV / Revenue 0x - - - - - 28.1x 25.3x
EV / EBITDA - - - -0x - -0.45x -0.5x -0.33x
EV / EBIT -0x -0x -0x -0x -0x -0.45x -0.42x -0.32x
EV / FCF -0x -0x - -0x -0x -0.72x -0.43x -0.38x
FCF Yield -62.6% -271% - -29.1% -42.8% -140% -231% -264%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 -11.1 -10.15 -10.31 -3.68 -5.9 -6.219 -4.954 -5.27
Distribution rate - - - - - - - -
Net sales 1 0.8817 - - - - - 2.011 2.233
EBITDA 1 - - - -48.13 - -126.1 -112.4 -171.2
EBIT 1 -55.99 -39.84 -45.08 -48.72 -85.31 -125.3 -135.6 -178.9
Net income 1 -45.64 -42.35 -44.6 -40.21 -78.54 -126.3 -137.1 -177.5
Net Debt - - - - - - - -
Reference price 2 18.471 3.315 6.040 11.800 8.140 2.745 2.745 2.745
Nbr of stocks (in thousands) 4,174 4,176 4,424 12,179 18,529 20,607 - -
Announcement Date 3/8/22 A 3/7/23 A 3/12/24 A 3/11/25 A 3/9/26 A - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
-0.48x - - - 62.03M
17.32x6.64x12.72x1.72% 66.37B
31.83x8.5x28.08x0.07% 58.86B
38.41x6.84x20.46x0.85% 55.22B
44.35x6.2x29.52x-.--% 47.21B
33.62x3.22x13.9x-.--% 42.45B
35.98x8.9x23.21x0.36% 36.44B
-19.28x55.7x-21.11x-.--% 35.19B
41.59x8.02x26.91x-.--% 32.66B
-74.36x14.09x-75.73x-.--% 26.73B
Average 14.90x 13.12x 6.44x 0.33% 40B
Weighted average by Cap. 21.61x 11.64x 11.39x 0.44%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Corbus Pharmaceuticals Holdings, Inc.

Historical PBR trend

Valuation ratios - PBR - Corbus Pharmaceuticals Holdings, Inc.

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Corbus Pharmaceuticals Holdings, Inc.

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Corbus Pharmaceuticals Holdings, Inc.

  1. Stock Market
  2. Stocks
  3. CRBP Stock
  4. Valuation Corbus Pharmaceuticals Holdings, Inc.